Viromed Medical AG (Q11) — Defensive Interval Ratio
Latest as of September 2025:
50 days
Viromed Medical AG (Q11) has a Defensive Interval Ratio of 50 days as of September 2025. Defensive assets of €8.43 Million (cash €-, short-term investments €8.43 Million, receivables €-) cover 50 days of daily cash needs of €168.75K/day.
Defensive Interval Ratio
50 days
Days of operational coverage
Defensive Assets
€8.43 Million
Cash + ST Investments + Receivables
Daily Cash Need
€168.75K
Current Liabilities ÷ 365
Current Liabilities
€61.59 Million
EUR
Annual Defensive Interval Ratio for Viromed Medical AG (None–None)
The table below presents the year-by-year Defensive Interval Ratio for Viromed Medical AG from None to None, covering 0 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. See Viromed Medical AG working capital to net assets to evaluate short-term liquidity relative to the company's equity base.
| Year | DIR (days) | Defensive Assets (EUR) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|
DIR = (Cash + Short-term Investments + Net Receivables) / (Daily Cash Expenses)